Search Results - "Torrealba, L"
-
1
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU
Published in Digestive and liver disease (24-10-2024)“…Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective,…”
Get full text
Journal Article -
2
Severe Spontaneous Cases of Bisphosphonate-Related Osteonecrosis of the Jaws
Published in Journal of oral and maxillofacial surgery (01-08-2007)Get full text
Journal Article -
3
Dom2Vec - Detecting DGA Domains Through Word Embeddings and AI/ML-Driven Lexicographic Analysis
Published in 2023 19th International Conference on Network and Service Management (CNSM) (30-10-2023)“…The timely identification of DNS queries to Domain Generation Algorithm (DGA) domains plays a critical role in mitigating malware propagation and its potential…”
Get full text
Conference Proceeding -
4
Phish Me If You Can - Lexicographic Analysis and Machine Learning for Phishing Websites Detection with PHISHWEB
Published in 2023 IEEE 9th International Conference on Network Softwarization (NetSoft) (19-06-2023)“…We introduce PHISHWEB, a novel approach to website phishing detection, which detects and categorizes malicious websites through a progressive, multi-layered…”
Get full text
Conference Proceeding -
5
Not all DGAs are Born the Same - Improving Lexicographic based Detection of DGA Domains through AI/ML
Published in 2023 7th Network Traffic Measurement and Analysis Conference (TMA) (26-06-2023)“…Timely identification of DNS queries to Domain Generation Algorithm (DGA) domains is crucial to limit malware propagation and its potential impact,…”
Get full text
Conference Proceeding -
6
P572 Evaluation of safety, pharmacokinetics and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis: A Phase Ib/IIa, randomized, double blind, placebo controlled clinical trial
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background OST-122 is an orally administered, GI-targeted and non-systemic JAK3/TYK2 inhibitor. In preclinical models and in healthy volunteers,…”
Get full text
Journal Article -
7
P687 Development of a panel of microbial markers to distinguish transient from pathological dysbiosis
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background Dysbiosis is a widely used but unspecific term. It has been defined as any change in the composition of resident microbial communities…”
Get full text
Journal Article -
8
DOP08 A novel multiomic approach to unravel the mechanisms of action of biologics and tofacitinib in Inflammatory Bowel Disease
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Inflammatory bowel diseases (IBD), which includes Crohn´s disease (CD) and ulcerative colitis (UC), are complex and heterogeneous diseases…”
Get full text
Journal Article -
9
P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background There are few data regarding the management on acute severe ulcerative colitis (ASUC) flare in patients with previous anti-TNF exposure. We…”
Get full text
Journal Article -
10
P033 Unrevealing new potential key mechanisms implicated in inflammatory bowel disease by multiomic approach
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Inflammatory bowel diseases (IBD), comprising Crohn´s disease (CD) and ulcerative colitis (UC), are characterised by chronic, relapsing and…”
Get full text
Journal Article -
11
DOP22 Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Inflammatory bowel diseases are complex conditions characterized by heterogeneity at clinical, immunological, molecular, genetic, and…”
Get full text
Journal Article -
12
P675 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases
Published in Journal of Crohn's and colitis (30-01-2023)“…Abstract Background Main aim: To assess the durability of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short…”
Get full text
Journal Article -
13
P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
Published in Journal of Crohn's and colitis (21-01-2022)“…Abstract Background Ulcerative proctitis may have a mild and less aggressive course, although evidence is scarce because these patients are excluded from…”
Get full text
Journal Article -
14
P458 Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background Pouchitis and Crohn′s-like disease of the pouch (CDP) can be refractory to conventional therapy. Evidence of biological therapy has been…”
Get full text
Journal Article -
15
P104 Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background Pouchitis and other inflammatory pouch diseases (IPD) are frequent in pouch-carrying patients operated for a previous diagnosis of…”
Get full text
Journal Article -
16
P372 Effectiveness and safety of immunosuppressants for pouch disorders: results from the RESERVO Study of GETECCU
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background Pouchitis and other inflammatory disorders of the pouch (IDP), such as Crohn′s-like disease of the pouch (CDP), are frequent in patients…”
Get full text
Journal Article -
17
P357 Long-term outcomes of biologic therapy in Crohn’s disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background The prevalence of penetrating disease in Crohn’s disease (CD) increases progressively over time, and evidence on the medical treatment of…”
Get full text
Journal Article -
18
P835 Correlation between microbial markers and faecal calprotectin in IBD patients
Published in Journal of Crohn's and colitis (15-01-2020)“…Abstract Background Crohn disease (CD) and Ulcerative colitis (UC) are characterised by episodes of exacerbations and remissions. Monitoring disease activity…”
Get full text
Journal Article -
19
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
Published in Therapeutic advances in gastroenterology (01-05-2019)“…Background: Inflammatory bowel disease (IBD) is associated with a considerable burden to the patient and society. However, current data on IBD incidence and…”
Get full text
Journal Article -
20
P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases
Published in Journal of Crohn's and colitis (25-01-2019)“…Abstract Background The irritable bowel syndrome (IBS) is a functional disorder affecting up to 20% of world population. So far, there is not a specific…”
Get full text
Journal Article